Article Correctness Is Author's Responsibility: Alteplase Impedes Progression of Post-Stroke Ischemic Brain Lesions

The article below may contain offensive and/or incorrect content.

In this randomized controlled trial of IV alteplase for ischemic stroke, researchers evaluated CT or brain MRI scans before treatment and 24 to 48 hours after treatment for acute lesion visibility, extent, and swelling.